Clinical Trial

Autologous Adipose Cells Therapy

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-04; most recent amendment 2025-05-30.
Trial Details
NCT Number NCT06869252
Lead Sponsor CERM INC.
Conditions Hair Loss/Baldness, Wrinkle Appearance, Volume, Fine Lines, Skin Elasticity, Hair Thinning, Skin Pigmentation, Skin Texture
Enrollment 40 participants
Start Date 2025-08-01
Primary Completion 2025-11-01 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-31